Evaxion Biotech share price logo

Evaxion Biotech

NASDAQ: EVAX

$3.15

-0.09

(-2.78%)

as on

Evaxion Biotech Stock Performance

as on August 28, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $3.14
    $3.30
    downward going graph

    0.32%

    Downside

    4.76%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.52
    $12.15
    downward going graph

    20.00%

    Downside

    285.71%

    Upside

    downward going graph

Evaxion Biotech share price movements today

Previous Close
$3.24
Open
$3.30
Volume
663.9K
Market Cap
$27.0M
Day's Low - High
$3.14 - $3.30
52 Week Low - High
$2.52 - $12.15

Evaxion Biotech Historical Returns

1 Month Return
+ 12.5 %
3 Month Return
-23.17 %
1 Year Return
+ 3.45 %
3 Year Return
-92.84 %
5 Year Return
-98.96 %

Evaxion Biotech Stock Fundamentals & Key Indicators

Check Evaxion Biotech market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$27.0M

EPS (TTM)

-1.53

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.1

Industry PE ratio

-1.6366929133858268

PEG Ratio

-0.0093195081885068

EBITDA

-10.9M

Revenue (TTM)

7.5M

Profit Margin

100.00%

Return On Equity TTM

-73.56%

Evaxion Biotech Stock Valuation

Track how Evaxion Biotech P/E has moved over time to understand its valuation trends.

Evaxion Biotech in the last 5 years

  • Overview

  • Trends

Lowest (-4.39x)

December 31, 2021

Today (-3.94x)

December 31, 2025

Industry (-1.64x)

December 31, 2025

Highest (-0.43x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -3.94x

Evaxion Biotech vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Evaxion Biotech with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$27.0M-98.96%-2.1100.00%NA
BUY$46.2B675.69%NA0.00%NA
BUY$138.7B173.88%31.9286.04%NA
BUY$59.7B-62.65%-7.98-12.57%NA
BUY$85.8B21.77%19.984.86%0.44%

Stock Returns calculator for Evaxion Biotech Stock including INR - Dollar returns

The Evaxion Biotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Evaxion Biotech investment value today

Current value as on today

₹1,12,734

Returns

₹12,734

(+12.73%)

Returns from Evaxion Biotech Stock

₹3,448 (+3.45%)

Dollar Impact

₹9,286 (+9.29%)

Analyst Recommendation on Evaxion Biotech Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Evaxion Biotech. Average target price of $11.25

Evaxion Biotech Share Price Target

Get share price movements and forecasts by analysts on Evaxion Biotech.

What analysts predicted

72%UPSIDE

Target Price

$11.25

Current Price

$3.15

Analyzed by

4 Analysts

Target

$11.25

Evaxion Biotech target price $11.25, a slight upside of 72% compared to current price of $3.15. According to 4 analysts rating.

Indian Investors' Interest in Evaxion Biotech Stock

Search interest for Evaxion Biotech Stock has increased by 249% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:249% versus previous 30 day period

Evaxion Biotech Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
0
0
0
3
-
0
7
-
-
Gross Profit
-
0
0
0
3
-
0
7
-
-
Operating Income
-5
-4
-4
-4
-1
-3
-4
3
-4
-3
EBITDA
-5
-4
1
-6
-1
-1
-4
5
-8
-3
Interest Expense
0
0
0
0
0
0
0
1
-1
0
Depreciation
0
0
-
-
-
-
-
-
-
-
Income Before Tax
-5
-4
0
-6
-2
-1
-5
4
-6
-3
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-5
-4
1
-6
-1
-1
-4
4
-5
-3
Net Profit Margin
0.00%
100.00%
100.00%
100.00%
100.00%
0.00%
100.00%
100.00%
0.00%
0.00%

Evaxion Biotech Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Dec 2023
Mar 2025
Dec 2025
Total Revenue
-
-
-
-
-
0
3
7
Gross Profit
0
0
-
-
-
0
3
7
Operating Income
-5
-11
-16
-25
-25
-22
-14
-9
EBITDA
-6
-11
-16
-24
-22
-21
-9
-7
Interest Expense
0
1
0
0
1
0
0
0
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-6
-12
-16
-24
-23
-22
-11
-8
Income Tax Expense
0
0
-1
0
0
0
0
0
Net Income
-5
-11
-15
-24
-23
-22
-10
-7
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%
100.00%
100.00%

Evaxion Biotech Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-5
-4
1
-6
-1
-1
-4
4
-5
-3
Operating Cash Flow
-4
-2
-
-
-
-
-
-
-
-
Investing Cash Flow
0
0
-
-
-
-
-
-
-
-
Financing Cash Flow
0
5
-
-
-
-
-
-
-
-
Change in Cash
-4
2
6
-
-
-
-
-
12
-

Evaxion Biotech Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Dec 2023
Mar 2025
Dec 2025
Net Income
-5
-11
-15
-24
-23
-22
-10
-7
Operating Cash Flow
-1
-7
-12
-21
-25
-17
-12
-6
Investing Cash Flow
0
0
0
-1
0
0
0
0
Financing Cash Flow
9
9
8
49
7
10
13
22
Change in Cash
6
2
-3
26
-18
-7
0
17

Mutual Funds that own Evaxion Biotech Stock

Check out the Mutual Funds with significant holdings in Evaxion Biotech.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
0.007445%
621

Global Institutional Holdings in Evaxion Biotech

Funds
Holdings
Advisor Group Holdings, Inc.
0%
Royal Bank of Canada
0%
Ikarian Capital, LLC
0.9%
SmartHarvest Portfolios, LLC
0.17%
Rathbone Brothers PLC
0.55%

Evaxion Biotech News & Key Events

  • img

    Today's Timeline - 03 October

    Fri, 06:30 PM

    -

    Evaxion to present new biomarker data for EVX-01 at SITC 2025 Annual Meeting and ESMO 2025 congress.

Insights on Evaxion Biotech

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 483.4% return, outperforming this stock by 480.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 25.4% return, outperforming this stock by 118.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, EVAX stock has moved down by -92.8%

About Evaxion Biotech

Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03, DNA-based cancer vaccine for the treatment of solid tumors; and EVX-04, a therapeutic cancer vaccine candidate, which is in phase 1 trial for acute myeloid leukemia. Its programs also include vaccines that are in pre-clinical stage, which includes EVX-B1, a multi-component prophylactic vaccine targeting skin and soft tissue infections with S. aureus bacteria; EVX-B2 to target multi-component prophylactic vaccine against gonorrhea bacteria; EVX-B3 to target bacterial pathogen associated with repeated infections; and EVX-V1, a multi-component prophylactic vaccine candidate for cytomegalovirus. The company was formerly known as Evaxion Biotech A/S and changed its name to Evaxion A/S in May 2025. Evaxion A/S was incorporated in 2008 and is based in Horsholm, Denmark.
OrganisationEvaxion Biotech
HeadquartersDr. Neergaards Vej, Horsholm, Denmark, 2970
IndustryBiotechnology
CEODr. Helen Katrina Tayton-Martin MBA, Ph.D.
E-voting on sharesClick here to vote

Key Management of Evaxion Biotech

Name

Title

Dr. Helen Katrina Tayton-Martin MBA, Ph.D.

Chief Executive Officer

Mr. Andreas Holm Mattsson M.Sc.

Founder & Chief AI Officer

Mr. Thomas Frederik Schmidt M.Sc.

Chief Financial Officer

Dr. Birgitte Rono Ph.D.

Chief Scientific Officer & COO

Mr. Benjamin Ole Wolthers

Vice President of Clinical Development

FAQs

What is Evaxion Biotech share price today?

Evaxion Biotech share price today is $3.15 as on at the close of the market. Evaxion Biotech share today touched a day high of $3.30 and a low of $3.14.

What is the 52 week high and 52 week low for Evaxion Biotech share?

Evaxion Biotech share touched a 52 week high of $12.15 on and a 52 week low of $2.52 on . Evaxion Biotech stock price today i.e. is closed at $3.15,which is 74.07% down from its 52 week high and 25.00% up from its 52 week low.

What is Evaxion Biotech's market capitalisation today?

Evaxion Biotech market capitalisation is $0.00T as on .

How to invest in Evaxion Biotech Stock (EVAX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Evaxion Biotech on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Evaxion Biotech Shares that will get you 0.4762 shares as per Evaxion Biotech share price of $3.15 per share as on August 28, 2026 at 8:45 am IST.

What is the minimum amount required to buy Evaxion Biotech Stock (EVAX) from India?

Indian investors can start investing in Evaxion Biotech (EVAX) shares with as little as ₹95.53 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.30 in Evaxion Biotech stock (as per the Rupee-Dollar exchange rate as on ). Based on Evaxion Biotech share’s latest price of $3.15 as on August 28, 2026 at 8:45 am IST, you will get 3.1746 shares of Evaxion Biotech. Learn more about fractional shares .

What are the returns that Evaxion Biotech has given to Indian investors in the last 5 years?

Evaxion Biotech stock has given -98.96% share price returns and 30.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?